Open Access

Tetrandrine attenuates ischemia/reperfusion‑induced neuronal damage in the subacute phase

  • Authors:
    • Yu Wang
    • Xinjun Cai
    • Zhiheng Wu
    • Leilei Tang
    • Lingqun Lu
    • Yinyin Xu
    • Xiaogang Bao
  • View Affiliations

  • Published online on: February 23, 2021     https://doi.org/10.3892/mmr.2021.11936
  • Article Number: 297
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ischemic stroke, the third leading cause of disability globally, imposes a notable economic burden. Tetrandrine (Tet), which has been widely used clinically, exhibits potential protective effects against stroke. However, there has been little pre‑clinical research to evaluate the therapeutic effects of Tet on stroke. The present study investigated the beneficial effect of Tet on ischemia‑reperfusion (I/R) injury and its underlying mechanism in rats. Rats were subjected to occlusion of the middle cerebral artery, then treated with Tet (30 mg/kg/day, intraperitoneal) in the subacute phase for 7 days. In order to detect the effects of Tet on the behavior of rats, modified neurological severity score and longa behavior, grasping capability and inclined plane tests were conducted on days 1, 3 and 7 following cerebral ischemia. In addition, neuronal apoptosis in the cortex and hippocampus following ischemia was assessed by Nissl staining and TUNEL assay. Finally, oxidative stress was evaluated by measurement of free radicals and immunofluorescence staining of LC3 was used to assess autophagy. Tet improved neurological function and decreased infarct volume in I/R injury rats. Tet also prevented neuronal apoptosis in the cortex and hippocampus region. In addition, Tet protected against oxidative damage following ischemia, which was reflected by decreased levels of nitric oxide and malondialdehyde and increased levels of glutathione (GSH) and GSH peroxidase. In addition, the expression levels of the autophagy marker LC3 decreased in the Tet treatment group. In conclusion, Tet attenuated I/R‑induced neuronal damage in the subacute phase by decreasing oxidative stress, apoptosis and autophagy.
View Figures
View References

Related Articles

Journal Cover

April-2021
Volume 23 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang Y, Cai X, Wu Z, Tang L, Lu L, Xu Y and Bao X: Tetrandrine attenuates ischemia/reperfusion‑induced neuronal damage in the subacute phase. Mol Med Rep 23: 297, 2021
APA
Wang, Y., Cai, X., Wu, Z., Tang, L., Lu, L., Xu, Y., & Bao, X. (2021). Tetrandrine attenuates ischemia/reperfusion‑induced neuronal damage in the subacute phase. Molecular Medicine Reports, 23, 297. https://doi.org/10.3892/mmr.2021.11936
MLA
Wang, Y., Cai, X., Wu, Z., Tang, L., Lu, L., Xu, Y., Bao, X."Tetrandrine attenuates ischemia/reperfusion‑induced neuronal damage in the subacute phase". Molecular Medicine Reports 23.4 (2021): 297.
Chicago
Wang, Y., Cai, X., Wu, Z., Tang, L., Lu, L., Xu, Y., Bao, X."Tetrandrine attenuates ischemia/reperfusion‑induced neuronal damage in the subacute phase". Molecular Medicine Reports 23, no. 4 (2021): 297. https://doi.org/10.3892/mmr.2021.11936